Cargando…

Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?

BACKGROUND: Cardiovascular magnetic resonance (CMR)–derived extracellular volume (ECV) requires a hematocrit (Hct) to correct contrast volume distributions in blood. However, the timely assessment of Hct can be challenging and has limited the routine clinical application of ECV. The goal of the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Mao-Yuan, Huang, Yu-Sen, Niisato, Emi, Chow, Kelvin, Juang, Jyh-Ming Jimmy, Wu, Cho-Kai, Yu, Hsi-Yu, Lin, Lian-Yu, Yang, Shun-Chung, Chang, Yeun-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702722/
https://www.ncbi.nlm.nih.gov/pubmed/33250055
http://dx.doi.org/10.1186/s12968-020-00689-x
_version_ 1783616601599246336
author Su, Mao-Yuan
Huang, Yu-Sen
Niisato, Emi
Chow, Kelvin
Juang, Jyh-Ming Jimmy
Wu, Cho-Kai
Yu, Hsi-Yu
Lin, Lian-Yu
Yang, Shun-Chung
Chang, Yeun-Chung
author_facet Su, Mao-Yuan
Huang, Yu-Sen
Niisato, Emi
Chow, Kelvin
Juang, Jyh-Ming Jimmy
Wu, Cho-Kai
Yu, Hsi-Yu
Lin, Lian-Yu
Yang, Shun-Chung
Chang, Yeun-Chung
author_sort Su, Mao-Yuan
collection PubMed
description BACKGROUND: Cardiovascular magnetic resonance (CMR)–derived extracellular volume (ECV) requires a hematocrit (Hct) to correct contrast volume distributions in blood. However, the timely assessment of Hct can be challenging and has limited the routine clinical application of ECV. The goal of the present study was to evaluate whether ECV measurements lead to significant error if a venous Hct was unavailable on the day of CMR. METHODS: 109 patients with CMR T1 mapping and two venous Hcts (Hct(0): a Hct from the day of CMR, and Hct(1): a Hct from a different day) were retrospectively identified. A synthetic Hct (Hct(syn)) derived from native blood T1 was also assessed. The study used two different ECV methods, (1) a conventional method in which ECV was estimated from native and postcontrast T1 maps using a region-based method, and (2) an inline method in which ECV was directly measured from inline ECV mapping. ECVs measured with Hct(0), Hct(1), and Hct(syn) were compared for each method, and the reference ECV (ECV(0)) was defined using the Hct(0). The error between synthetic (ECV(syn)) and ECV(0)was analyzed for the two ECV methods. RESULTS: ECV measured using Hct(1) and Hct(syn) were significantly correlated with ECV(0) for each method. No significant differences were observed between ECV(0) and ECV measured with Hct(1) (ECV(1); 28.4 ± 6.6% vs. 28.3 ± 6.1%, p = 0.789) and between ECV(0) and ECV calculated with Hct(syn) (ECV(syn); 28.4 ± 6.6% vs. 28.2 ± 6.2%, p = 0.45) using the conventional method. Similarly, ECV(0) was not significantly different from ECV(1) (28.5 ± 6.7% vs. 28.5 ± 6.2, p = 0.801) and ECV(syn) (28.5 ± 6.7% vs. 28.4 ± 6.0, p = 0.974) using inline method. ECV(syn) values revealed relatively large discrepancies in patients with lower Hcts compared with those with higher Hcts. CONCLUSIONS: Venous Hcts measured on a different day from that of the CMR examination can still be used to measure ECV. ECV(syn) can provide an alternative method to quantify ECV without needing a blood sample, but significant ECV errors occur in patients with severe anemia.
format Online
Article
Text
id pubmed-7702722
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77027222020-12-01 Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements? Su, Mao-Yuan Huang, Yu-Sen Niisato, Emi Chow, Kelvin Juang, Jyh-Ming Jimmy Wu, Cho-Kai Yu, Hsi-Yu Lin, Lian-Yu Yang, Shun-Chung Chang, Yeun-Chung J Cardiovasc Magn Reson Research BACKGROUND: Cardiovascular magnetic resonance (CMR)–derived extracellular volume (ECV) requires a hematocrit (Hct) to correct contrast volume distributions in blood. However, the timely assessment of Hct can be challenging and has limited the routine clinical application of ECV. The goal of the present study was to evaluate whether ECV measurements lead to significant error if a venous Hct was unavailable on the day of CMR. METHODS: 109 patients with CMR T1 mapping and two venous Hcts (Hct(0): a Hct from the day of CMR, and Hct(1): a Hct from a different day) were retrospectively identified. A synthetic Hct (Hct(syn)) derived from native blood T1 was also assessed. The study used two different ECV methods, (1) a conventional method in which ECV was estimated from native and postcontrast T1 maps using a region-based method, and (2) an inline method in which ECV was directly measured from inline ECV mapping. ECVs measured with Hct(0), Hct(1), and Hct(syn) were compared for each method, and the reference ECV (ECV(0)) was defined using the Hct(0). The error between synthetic (ECV(syn)) and ECV(0)was analyzed for the two ECV methods. RESULTS: ECV measured using Hct(1) and Hct(syn) were significantly correlated with ECV(0) for each method. No significant differences were observed between ECV(0) and ECV measured with Hct(1) (ECV(1); 28.4 ± 6.6% vs. 28.3 ± 6.1%, p = 0.789) and between ECV(0) and ECV calculated with Hct(syn) (ECV(syn); 28.4 ± 6.6% vs. 28.2 ± 6.2%, p = 0.45) using the conventional method. Similarly, ECV(0) was not significantly different from ECV(1) (28.5 ± 6.7% vs. 28.5 ± 6.2, p = 0.801) and ECV(syn) (28.5 ± 6.7% vs. 28.4 ± 6.0, p = 0.974) using inline method. ECV(syn) values revealed relatively large discrepancies in patients with lower Hcts compared with those with higher Hcts. CONCLUSIONS: Venous Hcts measured on a different day from that of the CMR examination can still be used to measure ECV. ECV(syn) can provide an alternative method to quantify ECV without needing a blood sample, but significant ECV errors occur in patients with severe anemia. BioMed Central 2020-11-30 /pmc/articles/PMC7702722/ /pubmed/33250055 http://dx.doi.org/10.1186/s12968-020-00689-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Su, Mao-Yuan
Huang, Yu-Sen
Niisato, Emi
Chow, Kelvin
Juang, Jyh-Ming Jimmy
Wu, Cho-Kai
Yu, Hsi-Yu
Lin, Lian-Yu
Yang, Shun-Chung
Chang, Yeun-Chung
Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
title Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
title_full Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
title_fullStr Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
title_full_unstemmed Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
title_short Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
title_sort is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702722/
https://www.ncbi.nlm.nih.gov/pubmed/33250055
http://dx.doi.org/10.1186/s12968-020-00689-x
work_keys_str_mv AT sumaoyuan isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT huangyusen isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT niisatoemi isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT chowkelvin isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT juangjyhmingjimmy isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT wuchokai isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT yuhsiyu isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT linlianyu isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT yangshunchung isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements
AT changyeunchung isatimelyassessmentofthehematocritnecessaryforcardiovascularmagneticresonancederivedextracellularvolumemeasurements